Lista de obras -

A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies

artículo científico publicado en 2019

Access to human embryonic stem cell lines ⬇️

artículo científico publicado el 8 de diciembre de 2011

Assessing state stem cell programs in the United States: how has state funding affected publication trends?

artículo científico publicado en 2015

Assessing the use of assisted reproductive technology in the United States by non-United States residents

artículo científico publicado en 2017

Challenges in the translation and commercialization of cell therapies

artículo científico publicado en 2015

Compliance with donor age recommendations in oocyte donor recruitment advertisements in the USA ⬇️

artículo científico publicado el 1 de diciembre de 2012

Conflicts of Interest and Effective Oversight of Assisted Reproduction Using Donated Oocytes

artículo científico publicado en 2015

Contribution of Assisted Reproductive Technology to Overall Births by Maternal Age in the United States, 2012-2014.

artículo científico publicado en 2017

Differences in the utilization of gestational surrogacy between states in the U.S.

artículo científico publicado en 2017

Enhancement of the ν = 5/2 fractional quantum Hall state in a small in-plane magnetic field ⬇️

artículo científico publicado el 9 de mayo de 2012

Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden

scientific article published on 05 March 2019

Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden

artículo científico publicado en 2019

Erratum: Revisiting the Warnock rule.

artículo científico publicado en 2017

Healthcare Resource Use, Cost, and Sick Leave Following Kidney Transplantation in Sweden: A Population-Based, 5-Year, Retrospective Study of Outcomes: COIN

article

Identifying under- and overperforming countries in research related to human embryonic stem cells

artículo científico publicado en 2008

Improving oversight of innovative medical interventions in Texas, USA

artículo científico publicado en 2012

Insights from patients' blogs and the need for systematic data on stem cell tourism

artículo científico publicado en 2010

Medical crowdfunding to access CAR T-cell therapy

artículo científico publicado en 2019

Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions

artículo científico publicado en 2017

Navigating Bioethical Waters: Two Pilot Projects in Problem-Based Learning for Future Bioscience and Biotechnology Professionals

artículo científico publicado en 2015

Part 6: The role of communication in better understanding unproven cellular therapies

artículo científico publicado en 2016

Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015

scientific article published on 05 June 2019

Policy uncertainty and the conduct of stem cell research

artículo científico publicado en 2011

Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective

artículo científico publicado en 2015

Research policy and the mobility of US stem cell scientists

scientific article published on 01 July 2006

Revisiting the Warnock rule.

artículo científico publicado en 2017

Risk disclosure and the recruitment of oocyte donors: are advertisers telling the full story?

artículo científico publicado en 2014

Science, ethics and communication remain essential for the success of cell-based therapies

article published in Brain circulation

Self-regulation, compensation, and the ethical recruitment of oocyte donors.

artículo científico publicado en 2010

State performance in pluripotent and adult stem cell research, 2009-2016

artículo científico publicado en 2018

The Oversight and Practice of Oocyte Donation in the United States, United Kingdom and Canada ⬇️

artículo científico publicado el 1 de marzo de 2011

The role of botulinum toxin type A in the radiation fibrosis syndrome: a preliminary report

scientific article published on 01 March 2008

The roles and responsibilities of physicians in patients' decisions about unproven stem cell therapies.

artículo científico publicado en 2012

Tracking and assessing the rise of state-funded stem cell research ⬇️

artículo científico publicado el 1 de diciembre de 2010

Tracking the rise of stem cell tourism

artículo científico publicado en 2010

Trends in the geographic distribution of human embryonic stem-cell research

artículo científico publicado en 2004

Lista de obras de

A multiscale simulation framework for the manufacturing facility and supply chain of autologous cell therapies

Access to human embryonic stem cell lines ⬇️

Assessing state stem cell programs in the United States: how has state funding affected publication trends?

Assessing the use of assisted reproductive technology in the United States by non-United States residents

Challenges in the translation and commercialization of cell therapies

Compliance with donor age recommendations in oocyte donor recruitment advertisements in the USA ⬇️

Conflicts of Interest and Effective Oversight of Assisted Reproduction Using Donated Oocytes

Contribution of Assisted Reproductive Technology to Overall Births by Maternal Age in the United States, 2012-2014.

Differences in the utilization of gestational surrogacy between states in the U.S.

Enhancement of the ν = 5/2 fractional quantum Hall state in a small in-plane magnetic field ⬇️

Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden

Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden

Erratum: Revisiting the Warnock rule.

Healthcare Resource Use, Cost, and Sick Leave Following Kidney Transplantation in Sweden: A Population-Based, 5-Year, Retrospective Study of Outcomes: COIN

Identifying under- and overperforming countries in research related to human embryonic stem cells

Improving oversight of innovative medical interventions in Texas, USA

Insights from patients' blogs and the need for systematic data on stem cell tourism

Medical crowdfunding to access CAR T-cell therapy

Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions

Navigating Bioethical Waters: Two Pilot Projects in Problem-Based Learning for Future Bioscience and Biotechnology Professionals

Part 6: The role of communication in better understanding unproven cellular therapies

Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015

Policy uncertainty and the conduct of stem cell research

Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective

Research policy and the mobility of US stem cell scientists

Revisiting the Warnock rule.

Risk disclosure and the recruitment of oocyte donors: are advertisers telling the full story?

Science, ethics and communication remain essential for the success of cell-based therapies

Self-regulation, compensation, and the ethical recruitment of oocyte donors.

State performance in pluripotent and adult stem cell research, 2009-2016

The Oversight and Practice of Oocyte Donation in the United States, United Kingdom and Canada ⬇️

The role of botulinum toxin type A in the radiation fibrosis syndrome: a preliminary report

The roles and responsibilities of physicians in patients' decisions about unproven stem cell therapies.

Tracking and assessing the rise of state-funded stem cell research ⬇️

Tracking the rise of stem cell tourism

Trends in the geographic distribution of human embryonic stem-cell research